Details for New Drug Application (NDA): 209992
✉ Email this page to a colleague
The generic ingredient in AMOXICILLIN AND CLAVULANATE POTASSIUM is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
Summary for 209992
Tradename: | AMOXICILLIN AND CLAVULANATE POTASSIUM |
Applicant: | Deva Holding As |
Ingredient: | amoxicillin; clavulanate potassium |
Patents: | 0 |
Pharmacology for NDA: 209992
Mechanism of Action | beta Lactamase Inhibitors |
Suppliers and Packaging for NDA: 209992
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET;ORAL | 209992 | ANDA | Devatis, Inc. | 73043-007 | 73043-007-20 | 20 TABLET, FILM COATED in 1 BOTTLE (73043-007-20) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG;EQ 125MG BASE | ||||
Approval Date: | Sep 15, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription